Glenmark Pharma gets RBI’s nod to raise FII limit to 49%

20 May 2015 Evaluate

Reserve Bank of India (RBI) has allowed foreign institutional investors (FIIs) to buy up to 49% stake in Glenmark Pharmaceuticals. FIIs through primary market and stock exchanges, can now purchase up to 49% of the paid up capital of the company under the Portfolio Investment Scheme (PIS).

In December, the company had received shareholder nod for enhancing the limit from 40% to 49% for the purchase of its equity shares and convertible debentures by FIIs. As on March 2015, FIIs hold 34.71% stake in the pharma major.

Glenmark Pharmaceuticals is a research-driven, global, integrated pharmaceutical company and ranked among the top 80 Pharma & Biotech companies of the world in terms of revenues as per SCRIP 100 Rankings.

Glenmark Pharma Share Price

1958.50 5.60 (0.29%)
11-Dec-2025 12:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.25
Dr. Reddys Lab 1274.00
Cipla 1508.40
Zydus Lifesciences 925.30
Lupin 2078.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×